Sports
IDEAYA Announces Webcast to Report Interim Phase 2 Data for Darovasertib and Regulatory Update from FDA Type C Meeting in Neoadjuvant Uveal Melanoma on Monday, September 23, 2024
By: investing_au
- Sep 23 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS